Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in surepath pap samples and the role of pre- and postcytology testing

Journal of Clinical Microbiology

Volumn 50, Issue 4, 2012, Pages 1281-1284

  Chernesky, M ^a   Jang, D ^a   Portillo, E ^a   Smieja, M ^a   Kapala, J ^b   Doucette, C ^b   Sumner, J ^b   Ewert, R ^c   MacRitchie, C ^d   Gilchrist, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b DYNACARE LABORATORIES   (Canada)

^c Evergreen Health Centre   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIOASSAY; CANADA; CELL VIABILITY; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOLOGY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PREVALENCE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE;

EID: 84858590463     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06595-11     Document Type: Article

References (9)

1. Centers for Disease Control and Prevention. 2010. Sexually transmitted disease surveillance, 2008. Centers for Disease Control and Prevention, Atlanta, GA.
2. Chernesky M, et al. 2007. Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep liquid-based Pap samples. J. Clin. Microbiol. 45:2355-2358. (Pubitemid 47295458)
3. Chernesky M, et al. 2006. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J. Clin. Microbiol. 44:400-405.
4. Chernesky M, et al. 2009. Validation of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath liquid-based Pap test samples taken with different collection devices. Sex. Transm. Dis. 36:581-583.
5. Chernesky M, et al. 2007. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. J. Clin. Microbiol. 45:2434-2438. (Pubitemid 47295470)
6. Chernesky M, Castriciano S, Jang D, Smieja M. 2006. Use of flocked swabs and a universal transport medium to enhance molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 44:1084-1086.
7. Khader SN, et al. 2010. APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database. Cytojournal 7:11.
8. Schachter J, et al. 2005. Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J. Clin. Microbiol. 43:1372-1373. (Pubitemid 40364964)
9. Scholes D, et al. 1996. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N. Engl. J. Med. 334:1362-1366. (Pubitemid 26152715)